Maria Elena Ainora
The Catholic University of America
Internal medicineRadiologyUltrasoundPerfusionLiver diseaseCirrhosisHepatocellular carcinomaEndoscopySorafenibPortal hypertensionRifaximinChronic liver diseaseDiseaseContrast-enhanced ultrasoundShear wave elastographyDynamic contrastLiver fibrosisIn patientNon invasiveMedicineMicrobiologyGastroenterology
37Publications
11H-index
764Citations
Publications 38
Newest
#1A. Liguori (CUA: The Catholic University of America)H-Index: 4
#2Maria Elena Ainora (CUA: The Catholic University of America)H-Index: 11
Last. Luca Miele (CUA: The Catholic University of America)H-Index: 39
view all 10 authors...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient'...
Source
#1Lucrezia Laterza (CUA: The Catholic University of America)H-Index: 10
#2Maria Elena Ainora (CUA: The Catholic University of America)H-Index: 11
Last. Maria Assunta Zocco (CUA: The Catholic University of America)H-Index: 33
view all 14 authors...
Abstract Aim To evaluate whether changes in bowel perfusion parameters measured by dynamic-CEUS (D-CEUS) can be used for monitoring response to therapy in active Crohn disease (CD). Methods Fifty-four CD patients were evaluated with d -CEUS before (T0) and after 2 (T1), 6 (T2) and 12 weeks (T3) of anti-TNFα therapy. Variations from baseline were calculated for: peak intensity, PI; area under the curve, AUC; slope of wash in, Pw; time to peak, TP; mean transit time, MTT (median percentage values)...
Source
#1Matteo GarcovichH-Index: 18
#2Enrico Di StasioH-Index: 32
Last. Maurizio PompiliH-Index: 84
view all 10 authors...
BACKGROUND&AIMS To date no study has explored the potential role of ElastPQ, a novel point-SWE technique, in the assessment of clinically significant portal hypertension. The aim of our study was to determine a liver stiffness (LS) cut-off value measured by ElastPQ and laboratory parameters that could help to identify those patients who can safely avoid screening endoscopy. METHODS Data were collected on 1422 patients who underwent ElastPQ measurement from January 2013 to January 2016 in our Dep...
Source
#1Maria Elena AinoraH-Index: 11
#2Roberto IezziH-Index: 20
Last. Maria Assunta ZoccoH-Index: 33
view all 15 authors...
BACKGROUND: Contrast-enhanced ultrasound (CEUS) with second-generation contrast agents performed 1-month after HCC treatment is almost as sensitive as contrast-enhanced computed tomography (CECT) in depicting the residual tumor. However, the efficacy of CEUS performed early after the procedure is still debated. AIM: We evaluated the diagnostic accuracy of CEUS for the assessment of tumour response shortly after locoregional therapy in patients with unresectable HCC. METHODS: Ninety-four patients...
Source
#1Mariella Faccia (CUA: The Catholic University of America)H-Index: 2
#2Maria Elena Ainora (CUA: The Catholic University of America)H-Index: 11
Last. Maria Assunta Zocco (CUA: The Catholic University of America)H-Index: 33
view all 8 authors...
: Portal vein thrombosis (PVT) represents a well-known complication during the natural course of liver cirrhosis (LC), ranging from asymptomatic cases to life-threating conditions related to portal hypertension and hepatic decompensation. Portal flow stasis, complex acquired hypercoagulable disorders and exogenous factors leading to endothelial dysfunction have emerged as key factors for PVT development. However, PVT occurrence remains unpredictable and many issues regarding its natural history,...
15 CitationsSource
#1Matteo Garcovich (CUA: The Catholic University of America)H-Index: 18
#2Mariella Faccia (CUA: The Catholic University of America)H-Index: 2
Last. Maurizio Pompili (CUA: The Catholic University of America)H-Index: 84
view all 16 authors...
Purpose Hepatocellular adenoma (HCA) is a rare benign monoclonal neoplasm, recently categorized on genetic and histopathological basis into four subtypes with different biological behaviors. Since contrast-enhanced ultrasonography (CEUS) is nowadays a well-established technique for liver nodule characterization, the aim of our study was to assess CEUS features of HCAs to identify criteria that correlate with different HCA subtypes as compared to histopathologic examination and other imaging moda...
3 CitationsSource
#1Silvia Pecere (CUA: The Catholic University of America)H-Index: 13
#2Grainne Holleran (CUA: The Catholic University of America)H-Index: 16
Last. Maria Assunta Zocco (CUA: The Catholic University of America)H-Index: 33
view all 7 authors...
Abstract Intestinal ultrasonography has emerged as a cheap, non-invasive and readily accessible modality for the assessment of a number of gastroenterological diseases. Over the last decade, particularly due to the widespread use of biological agents in Inflammatory Bowel Disease (IBD), guidelines regarding management and follow-up advise more regular disease assessment and surveillance in order to guide treatment adjustments, and provide more personalised care. Given the young age of the majori...
9 CitationsSource
#1Eleonora Terzi (UNIBO: University of Bologna)H-Index: 11
#2Massimo Iavarone (University of Milan)H-Index: 30
Last. Giuseppe Mogavero (University of Palermo)H-Index: 4
view all 25 authors...
Background & Aims The use of contrast enhanced ultrasound (CEUS) for the diagnosis of hepatocellular carcinoma (HCC) in cirrhosis was questioned because of the risk of a false positive diagnosis in cases of cholangiocarcinoma. The American College of Radiology has recently released a scheme (CEUS Liver Imaging Reporting and Data System [LI-RADS®]) to classify lesions at risk of HCC investigated by CEUS. The aim of the present study was to validate this LI-RADS scheme for the diagnosis of HCC. Me...
68 CitationsSource
#1Maria Elena AinoraH-Index: 11
#2Matteo GarcovichH-Index: 18
Last. Maria Assunta ZoccoH-Index: 33
view all 9 authors...
Source
#1Matteo GarcovichH-Index: 18
#2Maurizio PompiliH-Index: 84
Last. Maria Assunta ZoccoH-Index: 33
view all 11 authors...
Source